NPCE Earnings

Quarterly EPS
$-0.19
Q3 2024
$-0.18
Q4 2024
$-0.21
Q1 2025
$-0.26
Q2 2025
$-0.11
Q3 2025
$-0.08
Q4 2025
$-0.20
Q1 2026
$-0.18
Q2 2026
Latest Revenue22.8M
Latest Net Income-6200000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.1822.8M-6200000+17.1%+30.8%
Q1 2026-$0.2022.1M-6689000-2.0%+4.8%
Q4 2025-$0.0826.6M-2729000+23.9%+55.6%
Q3 2025-$0.1127.4M-3496000+29.9%+42.1%
Q2 2025-$0.2619.5M-8651000+1.3%+0.0%
Q1 2025-$0.2122.5M-6589000+24.3%+34.4%
Q4 2024-$0.1821.5M-5250000+19.2%+21.7%
Q3 2024-$0.1921.1M-5452000+28.2%+32.1%
Q2 2024-$0.2619.3M-7514000
Q1 2024-$0.3218.1M-8925000
Q4 2023-$0.2318.0M-6200000
Q3 2023-$0.2816.4M-7257000
Neuropace (NPCE) — Earnings